Fundz

Ironwood Appoints Dr. Jeffrey Silber as Chief Medical Officer

PUBLIC · IRWDJul 14, 2026

Position

Chief Medical Officer

Company

Ironwood Pharmaceuticals

Jeffrey Silber
BostonBiotechnologyHealth CareMedical

Description

Ironwood Pharmaceuticals announces the retirement of Dr. Michael Shetzline and the appointment of Dr. Jeffrey Silber as Chief Medical Officer

Quick answer

Ironwood Appoints Dr. Jeffrey Silber as Chief Medical Officer (July 14, 2026). Ironwood Pharmaceuticals is based in Boston, Massachusetts, United States.

Who is the new Chief Medical Officer at Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals named Jeffrey Silber Chief Medical Officer, announced July 14, 2026.
What did Ironwood Pharmaceuticals announce on July 14, 2026?
Ironwood Pharmaceuticals announces the retirement of Dr. Michael Shetzline and the appointment of Dr. Jeffrey Silber as Chief Medical Officer
What does Ironwood Pharmaceuticals do?
Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI...
Where is Ironwood Pharmaceuticals based?
Ironwood Pharmaceuticals is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Illuminare Biotechnologies (July 14, 2026), Vesalio (July 14, 2026), Infusion for Health (July 14, 2026) and Sharps Medical Waste Services (July 14, 2026) also announced leadership changes within 45 days of Ironwood Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ironwood Pharmaceuticals, and when

A new leader at Ironwood Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ironwood Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ironwood Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ironwood Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ironwood Pharmaceuticals

Location

100 Summer Street, Suite 2300

Boston, Massachusetts, United States

About

Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). In June 2023, the U.S. Food and Drug Administration also approved LINZESS for the treatment of functional constipation in pediatric patients ages 6-17 years-old. Under the guidance of our seasoned industry leaders, we continue to build upon our history of GI innovation and challenge what has been done before to shape what the future holds. We keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts. We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ironwood Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Ironwood Pharmaceuticals's next move

Learn about Strategic plan

Ironwood Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.